vs

Side-by-side financial comparison of CME Group (CME) and Expand Energy (EXE). Click either name above to swap in a different company.

Expand Energy is the larger business by last-quarter revenue ($3.3B vs $1.9B, roughly 1.7× CME Group). Expand Energy runs the higher net margin — 16.9% vs 0.1%, a 16.8% gap on every dollar of revenue. On growth, Expand Energy posted the faster year-over-year revenue change (63.5% vs 14.5%). Over the past eight quarters, Expand Energy's revenue compounded faster (29.6% CAGR vs 10.8%).

CME Group Inc. is an American financial services company based in Chicago, Illinois. It operates financial derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX), and the Commodity Exchange (COMEX). The company owns 27% of S&P Dow Jones Indices. It is the world's largest operator of financial derivatives exchanges. Its exchanges are platforms for trading in agricultural products, currencies, energy, i...

Expand Energy Corporation is the largest independent natural gas producer in the U.S., based on net daily production. Headquartered in Oklahoma City, the company operates in the Appalachian Basin of the Marcellus Formation in Pennsylvania and West Virginia, as well as the Haynesville Shale in Northwestern Louisiana.

CME vs EXE — Head-to-Head

Bigger by revenue
EXE
EXE
1.7× larger
EXE
$3.3B
$1.9B
CME
Growing faster (revenue YoY)
EXE
EXE
+49.0% gap
EXE
63.5%
14.5%
CME
Higher net margin
EXE
EXE
16.8% more per $
EXE
16.9%
0.1%
CME
Faster 2-yr revenue CAGR
EXE
EXE
Annualised
EXE
29.6%
10.8%
CME

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CME
CME
EXE
EXE
Revenue
$1.9B
$3.3B
Net Profit
$1.2M
$553.0M
Gross Margin
Operating Margin
0.1%
22.8%
Net Margin
0.1%
16.9%
Revenue YoY
14.5%
63.5%
Net Profit YoY
20.7%
238.6%
EPS (diluted)
$2.33

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CME
CME
EXE
EXE
Q1 26
$1.9B
Q4 25
$1.6B
$3.3B
Q3 25
$1.5B
$3.0B
Q2 25
$1.7B
$3.7B
Q1 25
$1.6B
$2.2B
Q4 24
$1.5B
$2.0B
Q3 24
$1.6B
$648.0M
Q2 24
$1.5B
Net Profit
CME
CME
EXE
EXE
Q1 26
$1.2M
Q4 25
$1.2B
$553.0M
Q3 25
$908.0M
$547.0M
Q2 25
$1.0B
$968.0M
Q1 25
$956.2M
$-249.0M
Q4 24
$874.6M
$-399.0M
Q3 24
$912.8M
$-114.0M
Q2 24
$883.2M
Operating Margin
CME
CME
EXE
EXE
Q1 26
0.1%
Q4 25
61.8%
22.8%
Q3 25
63.3%
24.4%
Q2 25
66.7%
34.4%
Q1 25
67.5%
-12.2%
Q4 24
62.1%
-19.3%
Q3 24
64.6%
-23.9%
Q2 24
65.3%
Net Margin
CME
CME
EXE
EXE
Q1 26
0.1%
Q4 25
71.7%
16.9%
Q3 25
59.1%
18.4%
Q2 25
60.6%
26.2%
Q1 25
58.2%
-11.3%
Q4 24
57.3%
-19.9%
Q3 24
57.6%
-17.6%
Q2 24
57.6%
EPS (diluted)
CME
CME
EXE
EXE
Q1 26
Q4 25
$3.24
$2.33
Q3 25
$2.49
$2.28
Q2 25
$2.81
$4.02
Q1 25
$2.62
$-1.06
Q4 24
$2.40
$-2.15
Q3 24
$2.50
$-0.85
Q2 24
$2.42

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CME
CME
EXE
EXE
Cash + ST InvestmentsLiquidity on hand
$2.4B
$616.0M
Total DebtLower is stronger
$3.4B
$5.0B
Stockholders' EquityBook value
$18.6B
Total Assets
$202.0B
$28.3B
Debt / EquityLower = less leverage
0.27×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CME
CME
EXE
EXE
Q1 26
$2.4B
Q4 25
$4.5B
$616.0M
Q3 25
$2.6B
$613.0M
Q2 25
$2.1B
$731.0M
Q1 25
$1.5B
$349.0M
Q4 24
$3.0B
$317.0M
Q3 24
$2.4B
$1.0B
Q2 24
$1.9B
Total Debt
CME
CME
EXE
EXE
Q1 26
$3.4B
Q4 25
$5.0B
Q3 25
$5.0B
Q2 25
$5.1B
Q1 25
$5.2B
Q4 24
$5.7B
Q3 24
Q2 24
Stockholders' Equity
CME
CME
EXE
EXE
Q1 26
Q4 25
$28.7B
$18.6B
Q3 25
$28.2B
$18.1B
Q2 25
$27.7B
$17.9B
Q1 25
$27.0B
$17.2B
Q4 24
$26.5B
$17.6B
Q3 24
$28.2B
$10.2B
Q2 24
$27.6B
Total Assets
CME
CME
EXE
EXE
Q1 26
$202.0B
Q4 25
$198.4B
$28.3B
Q3 25
$187.1B
$27.6B
Q2 25
$179.9B
$27.8B
Q1 25
$157.8B
$27.9B
Q4 24
$137.4B
$27.9B
Q3 24
$137.8B
$13.4B
Q2 24
$123.4B
Debt / Equity
CME
CME
EXE
EXE
Q1 26
Q4 25
0.27×
Q3 25
0.28×
Q2 25
0.29×
Q1 25
0.30×
Q4 24
0.32×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CME
CME
EXE
EXE
Operating Cash FlowLast quarter
$956.0M
Free Cash FlowOCF − Capex
$215.0M
FCF MarginFCF / Revenue
6.6%
Capex IntensityCapex / Revenue
22.6%
Cash ConversionOCF / Net Profit
1.73×
TTM Free Cash FlowTrailing 4 quarters
$1.8B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CME
CME
EXE
EXE
Q1 26
Q4 25
$1.1B
$956.0M
Q3 25
$968.1M
$1.2B
Q2 25
$1.1B
$1.3B
Q1 25
$1.1B
$1.1B
Q4 24
$1.0B
$382.0M
Q3 24
$1.0B
$422.0M
Q2 24
$776.9M
Free Cash Flow
CME
CME
EXE
EXE
Q1 26
Q4 25
$1.1B
$215.0M
Q3 25
$949.7M
$426.0M
Q2 25
$1.0B
$665.0M
Q1 25
$1.1B
$533.0M
Q4 24
$991.7M
$-154.0M
Q3 24
$973.2M
$124.0M
Q2 24
$758.7M
FCF Margin
CME
CME
EXE
EXE
Q1 26
Q4 25
66.8%
6.6%
Q3 25
61.8%
14.4%
Q2 25
61.5%
18.0%
Q1 25
67.1%
24.3%
Q4 24
65.0%
-7.7%
Q3 24
61.4%
19.1%
Q2 24
49.5%
Capex Intensity
CME
CME
EXE
EXE
Q1 26
Q4 25
2.0%
22.6%
Q3 25
1.2%
26.1%
Q2 25
1.1%
17.8%
Q1 25
0.9%
25.6%
Q4 24
1.7%
26.8%
Q3 24
1.9%
46.0%
Q2 24
1.2%
Cash Conversion
CME
CME
EXE
EXE
Q1 26
Q4 25
0.96×
1.73×
Q3 25
1.07×
2.20×
Q2 25
1.03×
1.37×
Q1 25
1.17×
Q4 24
1.16×
Q3 24
1.10×
Q2 24
0.88×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CME
CME

Segment breakdown not available.

EXE
EXE

Oil And Gas$2.3B70%
Natural Gas Marketing Sales$734.0M22%
Natural Gas Liquids Sales$174.0M5%
Natural Gas Liquids Marketing Sales$34.0M1%
Oil Marketing Sales$31.0M1%

Related Comparisons